|
|
||||||||||
|
Click on image to view larger version.
Figure 6 Mean (SD) melagatran plasma concentration (µmol/l) vs. time since oral administration of 15-, 30- and 60-mg doses of ximelagatran (n = 20 per group).
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |